These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32043787)

  • 1. ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.
    Godinho J; Casa-Nova M; Moreira-Pinto J; Simões P; Paralta Branco F; Leal-Costa L; Faria A; Lopes F; Teixeira JA; Passos-Coelho JL
    Oncologist; 2020 Feb; 25(2):e284-e290. PubMed ID: 32043787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer.
    Cella CA; Knoedler M; Hall M; Arcopinto M; Bagnardi V; Gervaso L; Pellicori S; Spada F; Zampino MG; Ravenda PS; Frassoni S; Passaro A; Milano M; Laffi A; Fazio N; Lordick F
    JAMA Netw Open; 2023 Feb; 6(2):e230010. PubMed ID: 36795409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
    Cella CA; Di Minno G; Carlomagno C; Arcopinto M; Cerbone AM; Matano E; Tufano A; Lordick F; De Simone B; Muehlberg KS; Bruzzese D; Attademo L; Arturo C; Sodano M; Moretto R; La Fata E; De Placido S
    Oncologist; 2017 May; 22(5):601-608. PubMed ID: 28424324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer.
    Cella CA; Djulbegovic B; Hozo I; Lordick F; Bagnardi V; Frassoni S; Gervaso L; Fazio N
    Eur J Cancer; 2024 Sep; 209():114234. PubMed ID: 39142210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in patients with pancreatic adenocarcinoma: Disease burden and initiation of ambulatory thromboprophylaxis.
    Heffley J; Ganguly E; Tompkins BJ; Ades S; Holmes CE; Zubarik R
    Pancreatology; 2024 Sep; 24(6):894-898. PubMed ID: 38960779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for thromboembolism in patients with cholangiocarcinoma.
    Pfrepper C; Knödler M; Schorling RM; Seehofer D; Petros S; Lordick F
    J Cancer Res Clin Oncol; 2022 Sep; 148(9):2415-2426. PubMed ID: 34499224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study.
    Vadhan-Raj S; McNamara MG; Venerito M; Riess H; O'Reilly EM; Overman MJ; Zhou X; Vijapurkar U; Kaul S; Wildgoose P; Khorana AA
    Cancer Med; 2020 Sep; 9(17):6196-6204. PubMed ID: 32663379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
    van Es N; Franke VF; Middeldorp S; Wilmink JW; Büller HR
    Thromb Res; 2017 Feb; 150():30-32. PubMed ID: 28002757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in metastatic pancreatic cancer.
    Laderman L; Sreekrishnanilayam K; Pandey RK; Handorf E; Blumenreich A; Sorice KA; Lynch SM; Cheema K; Nagappan L; Sosa IR; Dotan E; Vijayvergia N
    Eur J Haematol; 2023 Jun; 110(6):706-714. PubMed ID: 36941225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary thromboprophylaxis in cancer outpatients - real-world evidence.
    Liz-Pimenta J; Tavares V; Gramaça J; Rato J; Menezes M; Baleiras M; Guedes H; Reis J; Guedes C; Gomes R; Barbosa M; Sousa M; Khorana AA; Medeiros R
    J Thromb Thrombolysis; 2024 Jun; 57(5):805-814. PubMed ID: 38643312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.
    Di Nisio M; van Es N; Rotunno L; Anzoletti N; Falcone L; De Tursi M; Natoli C; Tinari N; Cavallo I; Valeriani E; Candeloro M; Guglielmi MD; Rutjes AWS; Porreca E
    J Thromb Thrombolysis; 2019 Jul; 48(1):125-133. PubMed ID: 30919253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
    Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
    Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
    Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
    J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Venous thromboembolism and pancreatic cancer].
    Frère C; Bournet B; Benzidia I; Jamelot M; Debourdeau P; Hij A; Rafii-Elayoubi H; Buscail L; Farge D;
    J Med Vasc; 2018 Jul; 43(4):246-254. PubMed ID: 29981733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A narrative review on the epidemiology, prevention, and treatment of venous thromboembolic events in the context of chronic venous disease.
    Kemp MT; Obi AT; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1557-1567. PubMed ID: 33866055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
    Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
    J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of two general venous thromboembolism risk-stratification models in predicting venous thromboembolic events in TB patients.
    Sharif-Kashani B; Azimi M; Tabarsi P; Sadr M; Shirzadi S
    Int J Mycobacteriol; 2022; 11(1):83-87. PubMed ID: 35295028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.